Petras Juzenas
Position:	Scientist, Ph.D.
Phone:	+47-22781205
Email:

Mini CV

Current Position: since 2006 - Scientist at the Department of Radiation Biology.

Main interest:
Nanomedicines for cancer detection and therapy

Projects:
2007-2011: Uptake and toxicity of quantum dots in cancer cells (supported by the Research Council of Norway).
2010-2012: Combination therapy with bortezomib, nanoparticles and radiation against cancer and neurodegenerative diseases (supported by the South-Eastern Norway Regional Health Authority).

Contact information:
Address: Department of Radiation Biology, Room J4004
Institute for Cancer Research, Norwegian Radium Hospital
Oslo University Hospital HF
Ullernchausseen 70, Montebello 0310, Oslo, Norway
Tel.: +47 22 78 12 05
Fax: +47 22 78 12 07
Email: petras.juzenas[a]rr-research.no
Internet: http://radium.no/juzenas

Previous positions and education:
* 2003-2005: Postdoc financed by the Norwegian Cancer Society (Kreftforeningen) in the “Group of Biophysics and PDT” (group leader Prof. J.Moan).
* 2002: Ph.D. at the University of Oslo (supervisor Prof. Ph.D. J.Moan).
* 1999-2002: Research fellow and Ph.D. student at the Institute for Cancer Research.
* 1999, 2000: Research visits (1-2 months) at the Notre-Dame Hospital (Montreal, Canada).
* 1998: Guest researcher financed by the Research Council of Norway (Forskningsrådet) at the Department of Biophysics of the Institute for Cancer Research.
* 1997-2000: Scientific assistant and doctoral student at the University of Vilnius (Lithuania).
* 1995-1997: Specialist at the state power enterprise "AB Lietuvos Energija".
* 1995: University degree in physics at the Faculty of Physics, University of Vilnius.
* 1988-1990: Extramural School of Young Physicists "Fotonas" (Siauliai University, Lithuania).
* 1979-1990: Secondary School (Zirmunai gymnasium) in Vilnius, Lithuania. Class with profound teaching in physics, mathematics and English (1983-1990).

Research fields
* Enhancement of radiation therapy with nanoparticles (since 2008).
* Bionanotechnology and nanomedicines (since 2005).
* Ultrasound mediated drug release from liposomes (2006-2007).
* ALA-PDT: Photodynamic therapy (PDT) with 5-aminolevulinic acid (ALA) (1998-2006).
* Spectroscopy, photobiophysics and photobiology (since 1993).

Memberships
* European Society for Photobiology (ESP, since 2001);
* Norwegian Society for Photobiology and Photomedicine (NOFFOF, since 2002);
* American Society for Photobiology (ASP, since 2003);
* Norwegian NanoMedicine Network (since 2007);
* European Platform for Photodynamic Medicine (EPPM, since 2008);
* European Technology Platform on Nanomedicine (ETPN, since 2008).

Scientific publications (2012-1995):

Peer-reviewed original articles

61. A.Kleinauskas, J.-K.Kim, G.-H.Choi, H.T.Kim, K.Røe, P.Juzenas (2012) Superparamagnetic magnetite nanoparticles for cancer theranostics. Rev. Nanosci. Nanotech. 1(4), 271-283.
60. A.Mikulich, S.Kavaliauskiene, P.Juzenas (2012) Blebbistatin, a myosin inhibitor, is phototoxic to human cancer cells under exposure to blue light. Biochim. Biophys. Acta 1820(7), 870–877.
59. S.Steponkiene, S.Kavaliauskiene, R.Purviniene, R.Rotomskis, P.Juzenas (2011) Quantum dots affect expression of CD133 surface antigen in melanoma cells. Int. J. Nanomed. 6, 2437-2444.
58. R.Generalov, S.Lukoseviciute, W.Chen, S.Kristensen, P.Juzenas (2011) Entrapment in phospholipid vesicles quenches photoactivity of quantum dots. Int. J. Nanomed. 6, 1875-1888.
57. I.L.Christensen, Y.-P.Sun, P.Juzenas (2011) Carbon dots as antioxidants and prooxidants. J. Biomed. Nanotech. 7(5), 667-676.
56. S.Rocha, R.Generalov, M.C.Pereira, P.Juzenas, M.A.N.Coelho (2011) Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention. Nanomedicine (Lond.) 6(1), 79-87.
55. R.Generalov, S.Lukoseviciute, A.Juzeniene, P.Juzenas (2010) Cytotoxicity and phototoxicity of red fluorescent nontargeted quantum dots. IEEE J. Select. Top. Quantum Electron. 16(4), 997-1003.
54. P.Juzenas, A.Juzeniene (2010) Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors. Photodiagn. Photodyn. Ther. 7(3), 152-157.
53. D.I.Morrow, P.A.McCarron, A.D.Woolfson, P.Juzenas, A.Juzeniene, V.Iani, J.Moan, R.F.Donnelly (2010) Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches. J. Pharm. Pharmacol. 62(6), 685-695.
52. D.I.Morrow, P.A.McCarron, A.D:Woolfson, P.Juzenas, A.Juzeniene, V.Iani, J.Moan, R.F.Donnelly (2010) Novel patch-based systems for the localised delivery of ALA-esters. J. Photochem. Photobiol. B:Biol. 101(1), 59-69.
51. D.I.Morrow, P.A.McCarron, A.D.Woolfson, P.Juzenas, A.Juzeniene, V.Iani, J.Moan, R.F.Donnelly (2010) Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses. J. Pharm. Sci. 99(8), 3486-3498.
50. P.Juzenas, A.Juzeniene, V.Iani, J.Moan (2009) Depth profile of protoporphyrin IX fluorescence in an amelanotic mouse melanoma model. Photochem. Photobiol. 85(3), 760-764.
49. R.F.Donnelly, P.A.McCarron, R.Al-Kassas, A.Juzeniene, P.Juzenas, V.Iani, A.D.Woolfson and J.Moan (2009) Influence of formulation factors on PpIX production and photodynamic action of novel ALA-loaded microparticles. Biopharmaceut. Drug Dispos. 30(2), 55-70.
48. P.Juzenas, W.Chen, Y.-P.Sun, M.A.N.Coelho, R.Generalov, N.Generalova, I.L.Christensen (2008) Review. Quantum dots and nanoparticles for photodynamic and radiation therapy of cancer. Adv. Drug Deliv. Rev. 60(15), 1600-1614 (Fig. 1 selected as cover image of Dec. 2008 issue).
47. P.Juzenas, R.Generalov, A.Juzeniene, J.Moan (2008) Generation of nitrogen oxide and oxygen radicals by quantum dots. J. Biomed. Nanotech. 4(4), 450–456.
46. R.F.Donnelly, D.I.Morrow, P.A.McCarron, A.D.Woolfson, A.Morrissey, P.Juzenas, A.Juzeniene, V.Iani, H.O.McCarthy, J.Moan (2008) Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer. Photochem. Photobiol. 85(1), 195-204.
45. R.F.Donnelly, D.I.Morrow, P.A.McCarron, A.D.Woolfson, A.Morrissey, P.Juzenas, A.Juzeniene, V.Iani V, H.O.McCarthy, J.Moan (2008) Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy. J. Control. Release 129(3), 154-162.
44. A.Bugaj, M. Kwitniewski, V. Iani, A. Juzeniene, P. Juzenas, L.W. Ma and J. Moan (2007) Photodynamic therapy with di-L-arginine protoporphyrinate on WiDr human colon adenocarcinoma xenografts in athymic nude mice. Photodiagn. Photodyn. Ther. 4, 237-241.
43. A.Juzeniene, P.Juzenas, V.Iani, J.Moan (2007) Topical applications of iron chelators in photosensitization. Photochem Photobiol Sci. 6(12), 1268-1274.
42. M.Kaliszewski, M.Kwasny, A.Juzeniene, P.Juzenas, A.Graczyk, L.-W-Ma, V.Iani, P.Mikolajewska and J.Moan (2007) Biological activity of 5-aminolevulinic acid and its methyl ester after storage under different conditions. J. Photochem. Photobiol. B:Biol. 87(2), 67-72.
41. A.Juzeniene, P.Juzenas, L.W.Ma, V.Iani, J.Moan (2006) Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin. Br. J. Dermatol. 155(4), 791-799.
40. A.Juzeniene, P.Juzenas, I.Bronshtein, A.Vorobey and J.Moan (2006) The influence of temperature on photodynamic cell killing in vitro with 5-aminolevulinic acid. J. Photochem. Photobiol. B:Biol. 64, 161-166.
39. R.F.Donnelly, P.Juzenas, P.A.McCarron, L.-W.Ma, A.D.Woolfson and J.Moan (2006) Influence of formulation factors on methyl-ALA-induced protoporphyrin IX accumulation in vivo. Photodiagn. Photodyn. Ther. 3(3), 190-201.
38. R.F.Donnelly, L.W.Ma, P.Juzenas, V.Iani, P.A.McCarron, A.D.Woolfson and J. Moan (2006) Topical bioadhesive patch systems enhance selectivity of protoporphyrin IX accumulation in tumours. Photochem. Photobiol. 82(3), 670-675.
37. P.Juzenas, A.Juzeniene, V.Iani and J.Moan (2006) The influence of light and darkness on cutaneous fluorescence in mice. Luminescence 21(3), 159-163.
36. M. von Beckerath, P.Juzenas, L.Löfgren, L.-W.Ma, V.Iani, Z.Malik and J.Moan (2006) Influence of physiological parameters on the production of protoporphyrin IX in human skin by topical application of 5-aminolevulinic acid and its hexylester. J. Med. Sci. 6(4), 546-553.
35. A.Veberg, O.S¸rheim, J.Moan, V.Iani, P.Juzenas, A.N.Nilsen and J.P.Wold (2006) Measurement of lipid oxidation and porphyrins in high oxygen modified atmosphere and vacuum-packed minced turkey and pork meat by fluorescence spectra and images. Meat Sci. 73(3), 511-520.
34. Z.Luksiene, P.Juzenas, and J.Moan (2006) Radiosensitization of tumours by porphyrins. Cancer Lett. 235(1), 40-47.
33. A.Bugaj, A.Juzeniene, P.Juzenas, V.Iani, L.W.Ma and J.Moan (2006) The effect of skin permeation enhancers on the formation of porphyrins in mouse skin during topical application of the methyl ester of 5-aminolevulinic acid. J. Photochem. Photobiol. B:Biol. 83(2), 94-97.
32. A.Bugaj, V.Iani, A.Juzeniene, P.Juzenas, L.-W.Ma and J.Moan (2006) The effect of dimethyl sulfoxide, 1-[2-(decylthio-)ethyl-]azacyclopentane-2-one and labrafac on porphyrin formation in mouse skin during topical application of methyl 5-aminolevulinate; a fluorescence and extraction study. Photodiagn. Photodyn. Ther. 3(1), 27-33.
31. R.F.Donnelly, P.A.McCarron, L.-W.Ma, P.Juzenas, V.Iani, J.Moan, A.A.Zawislak and A.D.Woolfson (2006) Facilitated Delivery of ALA to Inaccessible Regions via Bioadhesive Patch Systems. J. Environ. Pathol. Toxicol. Oncol. 25(1-2), 389-402.
30. L.Zhao, K.P.Nielsen, A.Juzeniene, P.Juzenas, V.lani, L.W.Ma, K.Stamnes, J.J.Stamnes and J.Moan (2006) Spectroscopic measurements of photoinduced processes in human skin after topical application of the hexylester of 5-aminolevulinic acid. J. Environ. Pathol. Toxicol. Oncol. 25(1-2), 307-320.
29. P.Juzenas and J.Moan (2006) Review. Singlet oxygen in photosensitization. J. Environ. Pathol. Toxicol. Oncol. 25(1-2), 29-50.
28. R.F.Donnelly, D.I.J.Morrow, P.A.McCarron, P.Juzenas and A.D.Woolfson (2006) Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues. J. Photochem. Photobiol. B:Biol. 82(1), 59-71.
27. K.P.Nielsen, A.Juzeniene, P.Juzenas, K.Stamnes, J.J.Stamnes and Johan Moan (2005) Choice of optimal wavelength for PDT: The significance of oxygen depletion. Photochem. Photobiol. 81(5), 1190-1194.
26. M.Kaliszewski, A.Juzeniene, P.Juzenas, M.Kwasny, J.Kaminski, Z.Dabrowski, J.Golinski and J.Moan (2005) Formation of protoporphyrin IX from carboxylic- and amino- derivatives of 5-aminolevulinic acid. Photodiagn. Photodynam. Ther. 2(2), 129-134.
25. P.Juzenas, A.Juzeniene and J.Moan (2005) Deferoxamine photosensitizes cancer cells in vitro. Biochem. Biophys. Res. Comm. 332(2), 388-391.
24. S.Kristiansson, A.Juzeniene, P.Juzenas, V.Iani, L.Löfgren and J.Moan (2005) Kinetics of protoporphyrin IX formation in rat oral mucosa and skin after application of 5-aminolevulinic acid and its methylester. Photochem. Photobiol. 81(2), 394-397.
23. J.P.Wold, A.Veberg, A.Nilsen, V.Iani, P.Juzenas and J.Moan (2005) The role of naturally occurring chlorophyll and porphyrins in light induced oxidation of dairy products. A study based on fluorescence spectroscopy and sensory analysis. Int. Dairy J. 15(4), 343-353.
22. A.Uzdensky, E.Kolpakova, A.Juzeniene, P.Juzenas and J.Moan (2005) The effect of sub-lethal ALA-PDT on cytoskeleton and adhesion of cultured human cancer cells. Biochim. Biophys. Acta 1722(1), 43-50.
21. A.Juzeniene, P.Juzenas, L.-W.Ma, V.Iani and J.Moan (2004) Effectiveness of CureLight lamps for 5-aminolevulinic acid photodynamic therapy. Lasers Med. Sci. 19(3), 139-149.
20. K.P.Nielsen, Z.Lu, P.Juzenas, J.J.Stamnes, K.Stamnes and J.Moan (2004) Reflectance spectra of pigmented and non-pigmented skin in the UV spectral region. Photochem. Photobiol. 80(3), 450-455.
19. A.B.Uzdensky, A.Juzeniene, E.Kolpakova, G.-O. Hjortland, P.Juzenas and J.Moan (2004) Photosensitization with protoporphyrin IX inhibits attachment of cancer cells to a substratum. Biochem. Biophys. Res. Comm. 322, 452-457.
18. P.Juzenas, A.Juzeniene, R.Rotomskis and J.Moan (2004) Spectroscopic evidence of monomeric aluminium phthalocyanine tetrasulphonate in aqueous solutions. J. Photochem. Photobiol. B:Biol. 75(1-2), 107-110.
17. J.Moan, L.-W.Ma, A.Juzeniene, V.Iani, P.Juzenas, F.Apricena and Q.Peng (2003) Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters. Int. J. Cancer 103(1), 132-135.
16. A.Juzeniene, L.-W.Ma, P.Juzenas, V.Iani, N.Lange and J.Moan (2002) Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissues in vivo. Cell. Mol. Biol. 48(8), 911-916.
15. P.Juzenas, A.Juzeniene, S.Stakland, V.Iani and J.Moan (2002) Photosensitizing effect of protoporphyrin IX in pigmented melanoma of mice. Biochem. Biophys. Res. Comm. 297(3), 468-472.
14. P.Juzenas, A.Juzeniene, O.Kaalhus, V.Iani and J.Moan (2002) Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo. Photochem. Photobiol. Sci. 1(10), 745-748.
13. P.Juzenas, S.Sharfaei, J.Moan and R.Bissonnette (2002) Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester. J. Photochem. Photobiol. B:Biol. 67(1), 11-17.
12. S.Sharfaei, P.Juzenas, J.Moan and R.Bissonnette (2002) Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice. Arch. Dermatol. Res. 294, 237-242.
11. R.Bissonnette, J.-F.Tremblay, P.Juzenas, M.Boushira and H.Lui (2002) Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques. J. Invest. Dermatol. 119(1), 77-83.
10. A.Juzeniene, P.Juzenas, O.Kaalhus, V.Iani and J.Moan (2002) Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin. Photochem. Photobiol. 76(4), 452-456.
9. A.Juzeniene, P.Juzenas, V.Iani and J.Moan (2002) Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model. Photochem. Photobiol. 76(3) 329-334.
8. J.Moan, J.T.H.M. van den Akker, P.Juzenas, L.W.Ma, E.Angell-Petersen, O.B.Gadmar and V.Iani (2001) On the basis for tumor selectivity in the 5-aminolevulinic acid-induced synthesis of protoporphyrin IX. J. Porphyr. Phthalocyanines 5, 170-176.
7. P.Juzenas, V.Iani, S.Bagdonas, R.Rotomskis and J.Moan (2001) Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light. J. Photochem. Photobiol. B:Biol. 61(1-2), 78-86.
6. M. von Beckerath, P.Juzenas, L.-W.Ma, V.Iani, L.Löfgren and J.Moan (2001) The influence of UV-exposure on 5-aminolevulinic acid-induced protoporphyrin IX production in skin. Photochem. Photobiol. 74(6), 825-828.
5. S.Bagdonas, L.-W.Ma, V.Iani, R.Rotomskis, P.Juzenas and J.Moan (2000) Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: a spectroscopic study. Photochem. Photobiol. 72(2), 186-192.
4. J.Moan, K.Berg, O.B.Gadmar, V.Iani, L.-W.Ma and P.Juzenas (1999) The temperature dependence of protoporphyrin IX production in cells and tissues. Photochem. Photobiol. 70(4), 669-673.
3. P.Juzenas, R.S¸rensen, V.Iani and J.Moan (1999) Uptake of topically applied 5-aminolevulinic acid and production of protoporphyrin IX in normal mouse skin: dependence on skin temperature. Photochem. Photobiol. 69(4), 478-481.
2. P.Juzenas, S.Bagdonas, G.Streckyte, J.Moan and R.Rotomskis (1999) [Endogenous photosensitizer protoporphyrin IX in photosensitized tumour therapy]. Medicina 35(3), 189-195. (in Lithuanian)
1. V.Gudelis, P.Juzenas, J.Slavenas, R.Rotomskis and J.Didziapetriene (1996) Investigation of fluorescence spectra of sensitized cancer tissues. Lith. J. Physics (Liet. Fiz. Z.) 36(4), 318-321.

Book chapters
7. A.Juzeniene, P.Juzenas and J.Moan (2010) Application of 5-aminolevulinic acid and its derivatives for photodynamic therapy in vitro and in vivo. In Photodynamic Therapy: Methods and Protocols (Methods in Molecular Biology), Ed. Charles J. Gomer, Humana Press, pp. 97-106.
6. R.F.Donnelly, P.Juzenas, P.A.McCarron, A.D.Woolfson and J.Moan (2006) Review. Drug delivery for topical photodynamic therapy: Difficulties and novel solutions. In Trends in Cancer Research, Trivandrum, vol. 2, pp. 1-20.
5. P.Juzenas (2005) Review. Lasers in therapy of human diseases. In Trends in Cancer Research, Trivandrum, vol. 1, pp. 93-103.
4. J.Moan and P.Juzenas (2004) Biological effects from combinations of drugs and light. In: Photostability of drugs and drug formulations, 2nd edition. Ed. H.H.T¸nnesen, CRC Press, Boca Raton, Florida, pp. 189-211.
3. J.Moan, B.Cunderlikova, A.Juzeniene, P.Juzenas, L.-W.Ma and V.Iani (2003) Tumour selectivity of photodynamic therapy. In Targeted Cancer Therapies - An Odyssey, Troms¸ Symposium 2003 (June 22–24). Eds. ¨.S.Bruland and T.Fl¿gstad. Ravnetrykk, Troms¸, pp. 208-213.
2. J.Moan, LW.Ma, V.Iani and P.Juzenas (2001) Mechanisms and Procedures in PDT. In Skin and Environment – Perception and Protection. 10th EADV Congress, Munich, 2001 (Munich, October 10-14, 2001), J.Ring, S.Weidinger, U.Darsow, Eds., pp. 641-647.
1. J.Moan, P.Juzenas and S.Bagdonas (2000) Review. Degradation and transformation of photosensitisers during light exposure. In Recent Research Developments in Photochemistry and Photobiology, Ed. S.G.Pandalai, Transworld Research Network, Trivandrum, Vol. 4, Part I, p. 121-132.

Full-text articles published in conference proceedings
10. S.Petrosiute, R.Purviniene, V.Pasukoniene, S.Lukosevciute, P.Juzenas, R.Rotomskis (2010) Characterization of cancer stem cells and their response to CdTe quantum dots. In 8th International Conference on Medical Physics, October 14-16, 2010, Kaunas, Lithuania, pp.71-76, ISSN 1822-5721.
9. A.Kleinauskas, S.Bagdonas, P.Juzenas (2010) The research on superparamagnetic magnetite nanoparticles for MR imaging and radiotherapy. In 53rd Scientific Conference for Young Students of Physics and Natural Sciences, March 24-27, 2010, Vilnius, Lithuania, pp.28-29, ISSN 2029-4425.
8. R.Generalov, I.L.Christensen, W.Chen, Y.-P.Sun, S.Kristensen, P.Juzenas (2009) Generation of singlet oxygen and other radical species by quantum dot and carbon dot nanosensitizers. In Photodynamic Therapy: Back to the Future, June 11-15, 2009, Seattle, WA, D.H.Kessel, Eds., Proc. SPIE 7380, 738072 (9 p.).
7. P.Juzenas, V.Iani and J.Moan (2000) Influence of temperature and anaesthesia on production of protoporphyrin IX induced by topical application of 5-aminolevulinic acid and its methylester in normal mouse skin. In Third Internet Conference on Photochemistry and Photobiology. http://www.photobiology.com/photobiology2000/juzenas
6. G.Streckyte, D.Frolov, S.Bagdonas, P.Juzenas and R.Rotomskis (1999) Can photodynamic dose be predicted on sensitizer's photophysical parameters? In Second Internet Conference on Photochemistry and Photobiology, paper 40. http://www.photobiology.com/photobiology99
5. R.Rotomskis, S.Bagdonas, P.Juzenas, D.Frolov and G.Streckyte (1999) Photomodification of sensitizers commonly used in photosensitized tumor therapy. In International Conference on Biomedical Optics, Q.Luo, B.Chance, L.V.Wang, S.L.Jacques, Eds., Proc. SPIE 3863, 489-495.
4. P.Juzenas, R.S¸rensen, V.Iani and J.Moan (1999) Clearance of protoporphyrin IX from mouse skin after topical application of 5-aminolevulinic acid and its methyl ester. In Photochemotherapy of Cancer and Other Diseases, B.Ehrenberg, K.Berg, Eds., Proc. SPIE 3563, 161-166.
3. R.S¸rensen, P.Juzenas, V.Iani and J.Moan (1999) Formation of protoporphyrin IX in mouse skin after topical application of 5-aminolevulinic acid and its methyl ester. In Photochemotherapy of Cancer and Other Diseases, B.Ehrenberg, K.Berg, Eds., Proc. SPIE 3563, 77-81.
2. P.Juzenas, J.Didziapetriene, L.Staciokiene, V.Gudelis, J.Slavenas and R.Rotomskis (1996) Photomodifications of photodrugs in tumours. In Photochemotherapy: Photodynamic Therapy and Other Modalities, B.Ehrenberg, G.Jori, J.Moan, Eds., Proc. SPIE 2625, 499-506.
1. V.Gudelis, P.Juzenas, J.Slavenas and R.Rotomskis (1995) [Fluorescence investigations of photosensitizers in cancerous cells]. In The materials of the 11th Belarussian-Lithuanian seminar “Lasers and optical non-linearity” (June 29-30, 1994, Minsk), 60-65. (in Russian)

Published abstracts
3. J.-F.Tremblay, G.Viau, P.Juzenas, H.Lui and R.Bissonnette (2001) Photodynamic therapy of psoriasis with oral aminolevulinic acid. J. Cutan. Med. Surg. 5(suppl.3, abstract), 55.
2. J.Moan, P.Juzenas, A.Juzeniene and L.W.Ma (2001) Mechanisms and procedures in photodynamic therapy. JEADV (J. Eur. Acad. Dermatol. Venereol.) 15(suppl.2, abstract), 78-79.
1. P.Juzenas, S.Bagdonas, J.Didziapetriene, L.Staciokiene and R.Rotomskis (1997) Fluorescence spectroscopy of sensitized cancerous and normal tissues ex vivo. Acta Bio-Optica et Informatica Medica (Abstracts of the International Symposium on Photodynamic therapy, June 12-14, 1997, Wroclaw, Poland) 3, p. 17.

PhD thesis
P.Juzenas (2002) Investigations of the endogenous photosensitizer protoporphyrin IX in hairless mouse skin by means of fluorescence spectroscopy. Dissertation for the Degree of Dr. Philos. Faculty of Mathematics and Natural Sciences, University of Oslo. No. 237, ISSN 1501-7710.

Diploma (MSc) thesis
P.Juzenas (1995) Investigation of fluorescence properties of porphyrin-type pigments. Department of Quantum Electronics, Faculty of Physics, University of Vilnius.

Publications generated by the Institute’s data base

Author network for Petras Juzenas by COREMINE medical

Publications 2012

Mikulich A, Kavaliauskiene S, Juzenas P (2012)
Blebbistatin, a myosin inhibitor, is phototoxic to human cancer cells under exposure to blue light
Biochim Biophys Acta, 1820 (7), 870-7
PubMed 22507270

Publications 2011

Christensen IL, Sun YP, Juzenas P (2011)
Carbon dots as antioxidants and prooxidants
J Biomed Nanotechnol, 7 (5), 667-76
PubMed 22195484

Generalov R, Kavaliauskiene S, Westrøm S, Chen W, Kristensen S, Juzenas P (2011)
Entrapment in phospholipid vesicles quenches photoactivity of quantum dots
Int J Nanomedicine, 6, 1875-88
PubMed 21931483

Rocha S, Generalov R, Pereira Mdo C, Peres I, Juzenas P, Coelho MA (2011)
Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention
Nanomedicine (Lond), 6 (1), 79-87
PubMed 21182420

Steponkiene S, Kavaliauskiene S, Purviniene R, Rotomskis R, Juzenas P (2011)
Quantum dots affect expression of CD133 surface antigen in melanoma cells
Int J Nanomedicine, 6, 2437-44
PubMed 22072879

Publications 2010

Generalov R, Lukoseviciute S, Juzeniene A, Juzenas P (2010)
Cytotoxicity and Phototoxicity of Red Fluorescent Nontargeted Quantum Dots
IEEE J. Sel. Top. Quantum Electron., 16 (4), 997-1003

Juzenas P, Juzeniene A (2010)
Reduction of cutaneous photosensitivity by application of ointment containing ferrous or cobaltous ions concomitant with the use of topical protoporphyrin IX precursors
Photodiagnosis Photodyn Ther, 7 (3), 152-7
PubMed 20728838

Juzeniene A, Juzenas P, Iani V, Moan J (2010)
Reflectance spectroscopy and fluorescein angiography applied to assess photodynamic response in healthy mouse skin treated with topical hexylaminolevulinate
Photodiagnosis Photodyn Ther, 7 (4), 239-45
PubMed 21112546

Juzeniene A, Juzenas P, Moan J (2010)
Application of 5-aminolevulinic acid and its derivatives for photodynamic therapy in vitro and in vivo
Methods Mol Biol, 635, 97-106
PubMed 20552342

Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
Novel patch-based systems for the localised delivery of ALA-esters
J Photochem Photobiol B, 101 (1), 59-69
PubMed 20634088

Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
Influence of penetration enhancers on topical delivery of 5-aminolevulinic acid from bioadhesive patches
J Pharm Pharmacol, 62 (6), 685-95
PubMed 20636855

Morrow DI, McCarron PA, Woolfson AD, Juzenas P, Juzeniene A, Iani V, Moan J, Donnelly RF (2010)
Hexyl aminolaevulinate is a more effective topical photosensitiser precursor than methyl aminolaevulinate and 5-aminolaevulinic acids when applied in equimolar doses
J Pharm Sci, 99 (8), 3486-98
PubMed 20222026

Petrosiute S, Purviniene R, Pasukoniene V, Lukosevciute S, Juzenas P, Rotomskis R (2010)
Characterization of cancer stem cells and their response to CdTe quantum dots
Med Phys Balt Stat, 8, 71-76
PublikaID 41

Publications 2009

Donnelly RF, McCarron PA, Al-Kassas R, Juzeniene A, Juzenas P, Iani V, Woolfson AD, Moan J (2009)
Influence of formulation factors on PpIX production and photodynamic action of novel ALA-loaded microparticles
Biopharm Drug Dispos, 30 (2), 55-70
PubMed 19226650

Donnelly RF, Morrow DI, McCarron PA, David Woolfson A, Morrissey A, Juzenas P, Juzeniene A, Iani V, McCarthy HO, Moan J (2009)
Microneedle arrays permit enhanced intradermal delivery of a preformed photosensitizer
Photochem Photobiol, 85 (1), 195-204
PubMed 18764907

Generalov R, Christensen IL, Chen W, Sun YP, Kristensen S, Juzenas P (2009)
Generation of singlet oxygen and other radical species by quantum dot and carbon dot nanosensitizers
PROC SPIE, 7380, 738072

Juzenas P, Juzeniene A, Iani V, Moan J (2009)
Depth profile of protoporphyrin IX fluorescence in an amelanotic mouse melanoma model
Photochem Photobiol, 85 (3), 760-4
PubMed 19140894

Publications 2008

Donnelly RF, Morrow DI, McCarron PA, Woolfson AD, Morrissey A, Juzenas P, Juzeniene A, Iani V, McCarthy HO, Moan J (2008)
Microneedle-mediated intradermal delivery of 5-aminolevulinic acid: potential for enhanced topical photodynamic therapy
J Control Release, 129 (3), 154-62
PubMed 18556084

Juzenas P, Chen W, Sun YP, Coelho MA, Generalov R, Generalova N, Christensen IL (2008)
Quantum dots and nanoparticles for photodynamic and radiation therapies of cancer
Adv Drug Deliv Rev, 60 (15), 1600-14
PubMed 18840487

Juzenas P, Generalov R, Juzeniene A, Moan J (2008)
Generation of Nitrogen Oxide and Oxygen Radicals by Quantum Dots
J. Biomed. Nanotechnol., 4 (4), 450-456

Publications 2007

Bugaj A, Kwitniewski M, Iani V, Juzeniene A, Juzenas P, Ma LW, Moan J (2007)
Photodynamic therapy with di-L-arginine protoporphyrinate on WiDr human colon adenocarcinoma xenografts in athymic nude mice
Photodiagnosis Photodyn. Ther., 4 (4), 237-241

Juzeniene A, Juzenas P, Iani V, Moan J (2007)
Topical applications of iron chelators in photosensitization
Photochem Photobiol Sci, 6 (12), 1268-74
PubMed 18046481

Kaliszewski M, Kwasny M, Juzeniene A, Juzenas P, Graczyk A, Ma LW, Iani V, Mikolajewska P, Moan J (2007)
Biological activity of 5-aminolevulinic acid and its methyl ester after storage under different conditions
J Photochem Photobiol B, 87 (2), 67-72
PubMed 17350278

Publications 2006

Bugaj A, Iani V, Juzeniene A, Juzenas P, Ma LW, Moan J (2006)
The effect of dimethylsulfoxide, 1-[2-(decylthio)ethyl]azacyclopentan-2-one and Labrafac (R) CC on porphyrin formation in normal mouse skin during topical application of methyl 5-aminolevulinate: A fluorescence and extraction study
Photodiagnosis Photodyn. Ther., 3 (1), 27-33

Bugaj A, Juzeniene A, Juzenas P, Iani V, Ma LW, Moan J (2006)
The effect of skin permeation enhancers on the formation of porphyrins in mouse skin during topical application of the methyl ester of 5-aminolevulinic acid
J Photochem Photobiol B, 83 (2), 94-7
PubMed 16442808

Donnelly RF, Juzenas P, McCarron PA, Ma LW, Woolfson AD, Moan J (2006)
Influence of formulation factors on methyl-ALA-induced protoporphyrin IX accumulation in vivo
Photodiagnosis Photodyn. Ther., 3 (3), 190-201

Donnelly RF, Ma LW, Juzenas P, Iani V, McCarron PA, Woolfson AD, Moan J (2006)
Topical bioadhesive patch systems enhance selectivity of protoporphyrin IX accumulation
Photochem Photobiol, 82 (3), 670-5
PubMed 16475870

Donnelly RF, McCarron PA, Ma LW, Juzenas P, Iani V, Woolfson AD, Zawislak AA, Moan J (2006)
Facilitated delivery of ALA to inaccessible regions via bioadhesive patch systems
J. Environ. Pathol. Toxicol. Oncol., 25 (1-2), 389-402

Donnelly RF, Morrow DI, McCarron PA, Juzenas P, Woolfson AD (2006)
Pharmaceutical analysis of 5-aminolevulinic acid in solution and in tissues
J Photochem Photobiol B, 82 (1), 59-71
PubMed 16242952

Juzenas P, Juzeniene A, Iani V, Moan J (2006)
The influence of light and darkness on cutaneous fluorescence in mice
Luminescence, 21 (3), 159-63
PubMed 16502394

Juzenas P, Moan J (2006)
Singlet oxygen in photosensitization
J. Environ. Pathol. Toxicol. Oncol., 25 (1-2), 29-50

Juzeniene A, Juzenas P, Bronshtein I, Vorobey A, Moan J (2006)
The influence of temperature on photodynamic cell killing in vitro with 5-aminolevulinic acid
J Photochem Photobiol B, 84 (2), 161-6
PubMed 16624569

Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2006)
Topical application of 5-aminolaevulinic acid, methyl 5-aminolaevulinate and hexyl 5-aminolaevulinate on normal human skin
Br J Dermatol, 155 (4), 791-9
PubMed 16965430

Luksiene Z, Juzenas P, Moan J (2006)
Radiosensitization of tumours by porphyrins
Cancer Lett, 235 (1), 40-7
PubMed 15946797

McCarron PA, Ma LW, Juzenas P, Lani V, Woolfson A, Zawislak AA, Moan J (2006)
Facilitated delivery of ALA to inaccessible regions via bioadhesive patch systems
J Environ Pathol Toxicol Oncol, 25 (1-2), 389-402
PubMed 16566730

Moan J, Juzenas P (2006)
Singlet oxygen in photosensitization
J Environ Pathol Toxicol Oncol, 25 (1-2), 29-50
PubMed 16566709

Veberg A, Sørheim O, Moan J, Iani V, Juzenas P, Nilsen AN, Wold JP (2006)
Measurement of lipid oxidation and porphyrins in high oxygen modified atmosphere and vacuum-packed minced turkey and pork meat by fluorescence spectra and images
Meat Sci, 73 (3), 511-20
PubMed 22062491

Zhao L, Nielsen KP, Juzeniene A, Juzenas P, Lani V, Ma LW, Stamnes K, Stamnes JJ, Moan J (2006)
Spectroscopic measurements of photoinduced processes in human skin after topical application of the hexyl ester of 5-aminolevulinic acid
J Environ Pathol Toxicol Oncol, 25 (1-2), 307-20
PubMed 16566726

Publications 2005

Juzenas P, Juzeniene A, Moan J (2005)
Deferoxamine photosensitizes cancer cells in vitro
Biochem Biophys Res Commun, 332 (2), 388-91
PubMed 15910749

Kaliszewski M, Juzeniene A, Juzenas P, Kwasny M, Kaminski J, Dabrowski Z, Golinski J, Moan J (2005)
Formation of protoporphyrin IX from carboxylic-and amino-derivatives of 5-aminolevulinic acid
Photodiagnosis Photodyn. Ther., 2 (2), 129-134

Kristiansson S, Juzeniene A, Juzenas P, Iani V, Löfgren L, Moan J (2005)
Kinetics of protoporphyrin IX formation in rat oral mucosa and skin after application of 5-aminolevulinic acid and its methylester
Photochem Photobiol, 81 (2), 394-7
PubMed 15535733

Nielsen KP, Juzeniene A, Juzenas P, Stamnes K, Stamnes JJ, Moan J (2005)
Choice of optimal wavelength for PDT: the significance of oxygen depletion
Photochem Photobiol, 81 (5), 1190-4
PubMed 15934793

Uzdensky A, Kolpakova E, Juzeniene A, Juzenas P, Moan J (2005)
The effect of sub-lethal ALA-PDT on the cytoskeleton and adhesion of cultured human cancer cells
Biochim Biophys Acta, 1722 (1), 43-50
PubMed 15716135

Wold JP, Veberg A, Nilsen A, Iani V, Juzenas P, Moan J (2005)
The role of naturally occurring chlorophyll and porphyrins in light-induced oxidation of dairy products. A study based on fluorescence spectroscopy and sensory analysis
Int. Dairy J., 15 (4), 343-353

Publications 2004

Juzenas P, Juzeniene A, Rotomskis R, Moan J (2004)
Spectroscopic evidence of monomeric aluminium phthalocyanine tetrasulphonate in aqueous solutions
J Photochem Photobiol B, 75 (1-2), 107-10
PubMed 15246357

Juzeniene A, Juzenas P, Ma LW, Iani V, Moan J (2004)
Effectiveness of different light sources for 5-aminolevulinic acid photodynamic therapy
Lasers Med Sci, 19 (3), 139-49
PubMed 15503248

Nielsen KP, Lu Z, Juzenas P, Stamnes JJ, Stamnes K, Moan J (2004)
Reflectance spectra of pigmented and nonpigmented skin in the UV spectral region
Photochem Photobiol, 80 (3), 450-5
PubMed 15623329

Uzdensky AB, Juzeniene A, Kolpakova E, Hjortland GO, Juzenas P, Moan J (2004)
Photosensitization with protoporphyrin IX inhibits attachment of cancer cells to a substratum
Biochem Biophys Res Commun, 322 (2), 452-7
PubMed 15325251

Publications 2003

Moan J, Ma LW, Juzeniene A, Iani V, Juzenas P, Apricena F, Peng Q (2003)
Pharmacology of protoporphyrin IX in nude mice after application of ALA and ALA esters
Int J Cancer, 103 (1), 132-5
PubMed 12455066

Publications 2002

Bissonnette R, Tremblay JF, Juzenas P, Boushira M, Lui H (2002)
Systemic photodynamic therapy with aminolevulinic acid induces apoptosis in lesional T lymphocytes of psoriatic plaques
J Invest Dermatol, 119 (1), 77-83
PubMed 12164928

Juzenas P, Juzeniene A, Kaalhus O, Iani V, Moan J (2002)
Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo
Photochem Photobiol Sci, 1 (10), 745-8
PubMed 12656473

Juzenas P, Juzeniene A, Stakland S, Iani V, Moan J (2002)
Photosensitizing effect of protoporphyrin IX in pigmented melanoma of mice
Biochem Biophys Res Commun, 297 (3), 468-72
PubMed 12270116

Juzenas P, Sharfaei S, Moan J, Bissonnette R (2002)
Protoporphyrin IX fluorescence kinetics in UV-induced tumours and normal skin of hairless mice after topical application of 5-aminolevulinic acid methyl ester
J Photochem Photobiol B, 67 (1), 11-7
PubMed 12007462

Juzeniene A, Juzenas P, Iani V, Moan J (2002)
Topical application of 5-aminolevulinic acid and its methylester, hexylester and octylester derivatives: considerations for dosimetry in mouse skin model
Photochem Photobiol, 76 (3), 329-34
PubMed 12403455

Juzeniene A, Juzenas P, Kaalhus O, Iani V, Moan J (2002)
Temperature effect on accumulation of protoporphyrin IX after topical application of 5-aminolevulinic acid and its methylester and hexylester derivatives in normal mouse skin
Photochem Photobiol, 76 (4), 452-6
PubMed 12405155

Juzeniene A, Ma LW, Juzenas P, Iani V, Lange N, Moan J (2002)
Production of protoporphyrin IX from 5-aminolevulinic acid and two of its esters in cells in vitro and tissues in vivo
Cell Mol Biol (Noisy-le-grand), 48 (8), 911-6
PubMed 12699250

Sharfaei S, Juzenas P, Moan J, Bissonnette R (2002)
Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in mice
Arch Dermatol Res, 294 (5), 237-42
PubMed 12115027

Publications 2001

Juzenas P, Iani V, Bagdonas S, Rotomskis R, Moan J (2001)
Fluorescence spectroscopy of normal mouse skin exposed to 5-aminolaevulinic acid and red light
J Photochem Photobiol B, 61 (1-2), 78-86
PubMed 11485851

Moan J, Ma LW, Iani V, Juzenas P (2001)
Mechanisms and procedures in PDT
SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, 641-647

Moan J, Van den Akker JTHM, Juzenas P, Ma LW, Angell-Petersen E, Gadmar OB, Iani V (2001)
On the basis for tumor selectivity in the 5-aminolevulinic acid-induced synthesis of protoporphyrin IX
J. Porphyr. Phthalocyanines, 5 (2), 170-176

von Beckerath M, Juzenas P, Ma LW, Iani V, Löfgren L, Moan J (2001)
The influence of UV exposure on 5-aminolevulinic acid-induced protoporphyrin IX production in skin
Photochem Photobiol, 74 (6), 825-8
PubMed 11783939

Publications 2000

Bagdonas S, Ma LW, Iani V, Rotomskis R, Juzenas P, Moan J (2000)
Phototransformations of 5-aminolevulinic acid-induced protoporphyrin IX in vitro: a spectroscopic study
Photochem Photobiol, 72 (2), 186-92
PubMed 10946571

Publications 1999

Juzenas P, Sorensen R, Iani V, Moan J (1999)
Clearance of protoporphyrin IX from mouse skin after topical application of 5-aminolevulinic acid and its methyl ester
P SOC PHOTO-OPT INS, 3563, 161-166

Juzenas P, Sørensen R, Iani V, Moan J (1999)
Uptake of topically applied 5-aminolevulinic acid and production of protoporphyrin IX in normal mouse skin: dependence on skin temperature
Photochem Photobiol, 69 (4), 478-81
PubMed 10212580

Moan J, Berg K, Gadmar OB, Iani V, Ma L, Juzenas P (1999)
The temperature dependence of protoporphyrin IX production in cells and tissues
Photochem Photobiol, 70 (4), 669-73
PubMed 10546563

Sorensen R, Juzenas P, Iani V, Moan J (1999)
Formation of protoporphyrin IX in mouse skin after topical application of 5-aminolevulinic acid and its methyl ester.
P SOC PHOTO-OPT INS, 3563, 77-81

Nov 23, 2012 [10740 visits]

Go back

Print this page

E-mail this page